96 related articles for article (PubMed ID: 1464961)
1. [Autoradiographic demonstration of 18F-FDG distribution within mouse FM3A tumor tissue in vivo].
Kubota R; Yamada S; Kubota K; Ishiwata K; Tamahashi N; Ido T
Kaku Igaku; 1992 Oct; 29(10):1215-21. PubMed ID: 1464961
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography.
Kubota R; Yamada S; Kubota K; Ishiwata K; Tamahashi N; Ido T
J Nucl Med; 1992 Nov; 33(11):1972-80. PubMed ID: 1432158
[TBL] [Abstract][Full Text] [Related]
3. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake.
Kubota R; Kubota K; Yamada S; Tada M; Ido T; Tamahashi N
J Nucl Med; 1994 Jan; 35(1):104-12. PubMed ID: 8271030
[TBL] [Abstract][Full Text] [Related]
4. Active and passive mechanisms of [fluorine-18] fluorodeoxyglucose uptake by proliferating and prenecrotic cancer cells in vivo: a microautoradiographic study.
Kubota R; Kubota K; Yamada S; Tada M; Ido T; Tamahashi N
J Nucl Med; 1994 Jun; 35(6):1067-75. PubMed ID: 8195872
[TBL] [Abstract][Full Text] [Related]
5. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG.
Kubota R; Kubota K; Yamada S; Tada M; Takahashi T; Iwata R; Tamahashi N
J Nucl Med; 1995 Mar; 36(3):484-92. PubMed ID: 7884515
[TBL] [Abstract][Full Text] [Related]
6. Micro-autoradiographic method to study [18F]FDG uptake in mouse tissue.
Kubota R; Yamada S; Kubota K; Ishiwata K; Ido T
Nucl Med Biol; 1993 Feb; 20(2):183-8. PubMed ID: 8448573
[TBL] [Abstract][Full Text] [Related]
7. Assessment of cancer recurrence in residual tumors after fractionated radiotherapy: a comparison of fluorodeoxyglucose, L-methionine and thymidine.
Reinhardt MJ; Kubota K; Yamada S; Iwata R; Yaegashi H
J Nucl Med; 1997 Feb; 38(2):280-7. PubMed ID: 9025756
[TBL] [Abstract][Full Text] [Related]
8. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue.
Yamada S; Kubota K; Kubota R; Ido T; Tamahashi N
J Nucl Med; 1995 Jul; 36(7):1301-6. PubMed ID: 7790960
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake.
Brown RS; Leung JY; Fisher SJ; Frey KA; Ethier SP; Wahl RL
J Nucl Med; 1996 Jun; 37(6):1042-7. PubMed ID: 8683298
[TBL] [Abstract][Full Text] [Related]
10. Autoradiographic evaluation of the intra-tumoral distribution of 2-deoxy-D-glucose and monoclonal antibodies in xenografts of human ovarian adenocarcinoma.
Brown RS; Fisher SJ; Wahl RL
J Nucl Med; 1993 Jan; 34(1):75-82. PubMed ID: 8418275
[TBL] [Abstract][Full Text] [Related]
11. Coincidence planar imaging for dynamic [18F]FDG uptake in nude mice with tumors and inflammation: correlated with histopathology and micro-autoradiography.
Sun YL; Jan ML; Kao PF; Fan KH; Hsu HT; Chang WC; Shen YC; Lee TW
Kaohsiung J Med Sci; 2005 Jun; 21(6):258-66. PubMed ID: 16035568
[TBL] [Abstract][Full Text] [Related]
12. Serum glucose: effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma.
Wahl RL; Henry CA; Ethier SP
Radiology; 1992 Jun; 183(3):643-7. PubMed ID: 1584912
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the regional uptake of radiolabeled deoxyglucose analogs in human tumor xenografts.
Dearling JL; Flynn AA; Sutcliffe-Goulden J; Petrie IA; Boden R; Green AJ; Boxer GM; Begent RH; Pedley RB
J Nucl Med; 2004 Jan; 45(1):101-7. PubMed ID: 14734681
[TBL] [Abstract][Full Text] [Related]
14. Metabolic fate of 18F-FDG in mice bearing either SCCVII squamous cell carcinoma or C3H mammary carcinoma.
Kaarstad K; Bender D; Bentzen L; Munk OL; Keiding S
J Nucl Med; 2002 Jul; 43(7):940-7. PubMed ID: 12097467
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: I. Are inflammatory cells important?
Brown RS; Leung JY; Fisher SJ; Frey KA; Ethier SP; Wahl RL
J Nucl Med; 1995 Oct; 36(10):1854-61. PubMed ID: 7562055
[TBL] [Abstract][Full Text] [Related]
16. FDG-PET evaluation of therapeutic effects on VX2 liver tumor.
Oya N; Nagata Y; Tamaki N; Takagi T; Murata R; Magata Y; Abe M; Konishi J
J Nucl Med; 1996 Feb; 37(2):296-302. PubMed ID: 8667065
[TBL] [Abstract][Full Text] [Related]
17. Imaging experimental brain tumors with 1-aminocyclopentane carboxylic acid and alpha-aminoisobutyric acid: comparison to fluorodeoxyglucose and diethylenetriaminepentaacetic acid in morphologically defined tumor regions.
Uehara H; Miyagawa T; Tjuvajev J; Joshi R; Beattie B; Oku T; Finn R; Blasberg R
J Cereb Blood Flow Metab; 1997 Nov; 17(11):1239-53. PubMed ID: 9390656
[TBL] [Abstract][Full Text] [Related]
18. [Comparative distribution study of 14C labeled amino acids, glucose-analogue and precursor of nuclei acid, as tumor seeking agents].
Shiba K; Mori H; Hisada K
Radioisotopes; 1984 Aug; 33(8):526-32. PubMed ID: 6505304
[TBL] [Abstract][Full Text] [Related]
19. Comparative PET imaging of experimental tumors with bromine-76-labeled antibodies, fluorine-18-fluorodeoxyglucose and carbon-11-methionine.
Lövqvist A; Sundin A; Roberto A; Ahlström H; Carlsson J; Lundqvist H
J Nucl Med; 1997 Jul; 38(7):1029-35. PubMed ID: 9225786
[TBL] [Abstract][Full Text] [Related]
20. Oral 18F-fluoro-2-deoxyglucose for primate PET studies without behavioral restraint: demonstration of principle.
Martinez ZA; Colgan M; Baxter LR; Quintana J; Siegel S; Chatziioannou A; Cherry SR; Mazziotta JC; Phelps ME
Am J Primatol; 1997; 42(3):215-24. PubMed ID: 9209586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
